[KTTA] YoY Quarter Result on 30-Sep-2021 [#Q3]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
18-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -109.62%
YoY- -10,800.00%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 219 0 0 -
PBT -3,613 -4,586 -1,526 -14 536.66%
Tax -162 671 0 0 -
NP -3,613 -5,257 -1,526 -14 536.66%
Tax Rate - - - - -
Total Cost 3,613 5,475 1,526 14 536.66%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 -2,404.65 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -2.87 -0.20 -0.17 -0.00 -
EPS Diluted -2.87 -0.20 -0.17 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.